| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Platform: GPL24247
|
Homo sapiens
|
RESULTS
|
|||||
| GSE196447 |
Down Syndrome
|
|
75 |
|
Victor Tybulewicz | Jan 25, 2024 | ||
| GSE203322 |
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state
|
|
60 | Masaki Nomura | Oct 31, 2023 | |||
| GSE207163 |
Transcriptional repression by a secondary DNA binding surface of DNA topoisomerase I safeguards against hypertranscription
|
|
62 | Zhenhua hu | May 29, 2023 | |||
| GSE234148 |
Pharmacological HDAC inhibition impairs pancreatic β-cell function through a genome-wide epigenomic reprogramming [RNA-seq]
|
|
24 |
|
Frederik Oger | Aug 08, 2023 | ||
| GSE240505 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma [RNA-seq]
|
|
22 |
|
Hongjian Jin | Mar 04, 2024 | ||
| GSE240506 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|
|
26 |
|
Hongjian Jin | Mar 02, 2024 | ||
| GSE249541 |
Extracellular niche and tumor microenvironment enhance the impact of KRAS inhibitors in pancreatic cancer models.
|
|
47 | Christos Fountzilas | Jan 24, 2024 |
